Seven labs at FDA's Center for Biologics Evaluation and Research are working in a consortium to fill in gaps in knowledge about how stem cells function. This research could ultimately be key to the advancement of personalized medicine, in which medical treatment is tailored to the needs of an individual patient.
"It's not science fiction," explains Steven R. Bauer, Ph.D., chief of the Cellular and Tissue Therapy Branch in FDA's Office of Cellular Tissue and Gene Therapies. "For me, regenerative medicine is the most exciting part of what we regulate in our office."
Read the Consumer Update to learn more about their research and its implications.
For advertising/ promotion on HealthNewsDigest.com, call Mike McCurdy at: 877-634-9180. We have over 7,000 journalists as subscribers and may use our content